REASONS TO CONSIDER TAKING A GLP-1 RA Your clinician can help you decide if starting a GLP-1 RA is right for you
The European Medicines Agency's European Public Assessment Report (EPAR) for Wegovy does not highlight thermoregulatory concerns as a safety signal
As enforcement looms, access to compounded versions will diminish, potentially leading to increased costs and limited availability for patients. However, the direct-to-consumer programs introduced by Novo Nordisk and Eli Lilly aim to bridge this gap by providing authentic, FDA-approved medications at more accessible price points
Sermorelin acts as a selective agonist at the GHRH receptor (GHRHR), a class B G-protein-coupled receptor expressed on somatotroph cells of the anterior pituitary
Data availability The data that support the findings of this study are available from the corresponding author, F.G., upon reasonable request
Why This Matters For patients and healthcare providers who depend on compounded Tirzepatide, the judges decision provides temporary relief